CEO Jeremy Allaire executes 30 separate sales totaling 59.2K shares for $4.9M via 10b5-1 plan on 2026-06-05.
Jeremy Allaire, Chairman and CEO, filed 30 separate sales totaling 59.2K shares for $4.9M on 2026-06-05 at prices ranging from $79.11 to $87.95, with a blended average of $82.93. This transaction is part of a pre-arranged 10b5-1 trading plan and therefore scheduled, not discretionary. The sale reduces Allaire's holdings from 124.1K shares to 64.9K shares, a reduction of 47.7% of his pre-transaction position. The stock currently trades at $81.10, down 28.6% over the past 30 days and down from a 52-week high of $298.99 (-72.9%). While his cross-ticker track record shows an average 90-day return of +39.4% following prior sells, his five same-ticker prior sales at CRCL (all on 2026-02-26) each posted a 90-day return of +14.0%, suggesting a different pattern at this specific ticker. The company reported $694.1M in latest-quarter revenue with annual growth of +63.9%, but remains unprofitable on a full-year basis despite posting $55.3M in recent net income.